Not all type 2 microdeletions can be PCR amplified by a primer set for common breakpoints, and thus we cannot rule out the involvement of NF1-REPs or the SUZ12 sequences in the deletion identified in tumor P004-7N, because MLPA results were consistent with this type of deletion. This evidence concerns the gene NF1 and neoplasm.